BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34529043)

  • 1. Comparison of risk prediction models in infarct-related cardiogenic shock.
    Freund A; Pöss J; de Waha-Thiele S; Meyer-Saraei R; Fuernau G; Eitel I; Feistritzer HJ; Rubini M; Huber K; Windecker S; Montalescot G; Oldroyd K; Noc M; Zeymer U; Ouarrak T; Schneider S; Baran DA; Desch S; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(8):890-897. PubMed ID: 34529043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Mortality Risk Models in Patients with Postcardiac Arrest Cardiogenic Shock and Percutaneous Mechanical Circulatory Support.
    Chatzis G; Markus B; Syntila S; Waechter C; Luesebrink U; Ahrens H; Divchev D; Schieffer B; Karatolios K
    J Interv Cardiol; 2021; 2021():8843935. PubMed ID: 33536855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COMPARISON OF THE PREDICTIVE PERFORMANCE OF CARDIOGENIC SHOCK SCORES IN A REAL-WORLD LATIN AMERICA COUNTRY.
    Ortega-Hernández J; González-Pacheco H; Nieto RG; Araiza-Garaygordobil D; Lara-Martínez DS; De La Cruz JLB; Mendoza-García S; Altamirano-Castillo A; Orozco ÁM; Herrera LAB; Hernández-Montfort J; Aguilar-Montaño KM; Uriona LAS; López JÁFM; Loría CAL; Arias-Mendoza A
    Shock; 2023 Apr; 59(4):576-582. PubMed ID: 36821419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Prognostic Accuracy of Risk Prediction Models for Cardiogenic Shock.
    Miller RJH; Southern D; Wilton SB; James MT; Har B; Schnell G; van Diepen S; Grant ADM
    J Intensive Care Med; 2020 Dec; 35(12):1513-1519. PubMed ID: 31610748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial.
    Fuernau G; Fengler K; Desch S; Eitel I; Neumann FJ; Olbrich HG; de Waha A; de Waha S; Richardt G; Hennersdorf M; Empen K; Hambrecht R; Jung C; Böhm M; Pöss J; Strasser RH; Schneider S; Ouarrak T; Schuler G; Werdan K; Zeymer U; Thiele H
    Clin Res Cardiol; 2016 Dec; 105(12):1030-1041. PubMed ID: 27378612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical picture, management and risk stratification in patients with cardiogenic shock: does gender matter?
    Collado-Lledó E; Llaó I; Rivas-Lasarte M; González-Fernández V; Noriega FJ; Hernández-Perez FJ; Alegre O; Sionis A; Lidón RM; Viana-Tejedor A; Segovia-Cubero J; Ariza-Solé A
    BMC Cardiovasc Disord; 2020 Apr; 20(1):189. PubMed ID: 32664921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction.
    Pöss J; Köster J; Fuernau G; Eitel I; de Waha S; Ouarrak T; Lassus J; Harjola VP; Zeymer U; Thiele H; Desch S
    J Am Coll Cardiol; 2017 Apr; 69(15):1913-1920. PubMed ID: 28408020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early risk stratification in patients with cardiogenic shock irrespective of the underlying cause - the Cardiogenic Shock Score.
    Beer BN; Jentzer JC; Weimann J; Dabboura S; Yan I; Sundermeyer J; Kirchhof P; Blankenberg S; Schrage B; Westermann D
    Eur J Heart Fail; 2022 Apr; 24(4):657-667. PubMed ID: 35119176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patients.
    Rivas-Lasarte M; Sans-Roselló J; Collado-Lledó E; González-Fernández V; Noriega FJ; Hernández-Pérez FJ; Fernández-Martínez J; Ariza A; Lidón RM; Viana-Tejedor A; Segovia-Cubero J; Harjola VP; Lassus J; Thiele H; Sionis A
    Eur Heart J Acute Cardiovasc Care; 2020 Jan; ():. PubMed ID: 32004078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Risk Models in the Prediction of 30-Day Mortality in Acute Myocardial Infarction-Associated Cardiogenic Shock.
    Ranard LS; Guber K; Fried J; Takeda K; Kaku Y; Karmpaliotis D; Sayer G; Rabbani L; Burkhoff D; Uriel N; Kirtane AJ; Masoumi A
    Struct Heart; 2022 Nov; 6(6):100116. PubMed ID: 37288128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction.
    Ceglarek U; Schellong P; Rosolowski M; Scholz M; Willenberg A; Kratzsch J; Zeymer U; Fuernau G; de Waha-Thiele S; Büttner P; Jobs A; Freund A; Desch S; Feistritzer HJ; Isermann B; Thiery J; Pöss J; Thiele H
    Eur Heart J; 2021 Jun; 42(24):2344-2352. PubMed ID: 33647946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of SYNTAX Score in Patients With Infarct-Related Cardiogenic Shock: Insights From the CULPRIT-SHOCK Trial.
    Guedeney P; Barthélémy O; Zeitouni M; Hauguel-Moreau M; Hage G; Kerneis M; Lattuca B; Overtchouk P; Rouanet S; Fuernau G; de Waha-Thiele S; Zeymer U; Sandri M; Akin I; Desch S; Thiele H; Montalescot G
    JACC Cardiovasc Interv; 2020 May; 13(10):1198-1206. PubMed ID: 32438990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock.
    Prondzinsky R; Unverzagt S; Lemm H; Wegener NA; Schlitt A; Heinroth KM; Dietz S; Buerke U; Kellner P; Loppnow H; Fiedler MG; Thiery J; Werdan K; Buerke M
    Clin Res Cardiol; 2012 May; 101(5):375-84. PubMed ID: 22212516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of outcome scores in patients suffering from cardiogenic shock complicating AMI: APACHE II, APACHE III, Elebute-Stoner, SOFA, and SAPS II.
    Kellner P; Prondzinsky R; Pallmann L; Siegmann S; Unverzagt S; Lemm H; Dietz S; Soukup J; Werdan K; Buerke M
    Med Klin Intensivmed Notfmed; 2013 Nov; 108(8):666-74. PubMed ID: 23558639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.
    Prondzinsky R; Unverzagt S; Lemm H; Wegener N; Heinroth K; Buerke U; Fiedler M; Thiery J; Haerting J; Werdan K; Buerke M
    Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):476-84. PubMed ID: 22810435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
    Prondzinsky R; Lemm H; Swyter M; Wegener N; Unverzagt S; Carter JM; Russ M; Schlitt A; Buerke U; Christoph A; Schmidt H; Winkler M; Thiery J; Werdan K; Buerke M
    Crit Care Med; 2010 Jan; 38(1):152-60. PubMed ID: 19770739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of severity scales for cardiogenic shock in-hospital mortality. Proposal for a new prognostic model.
    Álvarez-Avello JM; Hernández-Pérez FJ; Herrero-Cano Á; López-Ibor JV; Aymerich M; Iranzo R; Vidal-Fernández M; Gómez-Bueno M; Gómez-Paratcha B; García-Suárez J; Martín CE; Forteza A; González-Román A; Segovia-Cubero J
    Rev Esp Anestesiol Reanim (Engl Ed); 2022 Feb; 69(2):79-87. PubMed ID: 35177367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison on the predictive value of different scoring systems for risk of short-term death in patients with acute myocardial infarction complicating cardiogenic shock].
    Guo C; Luo XL; Gao XJ; Wang J; Liu R; Li J; Zhang J; Yang WX; Hu FH; Wu Y; Yang YJ; Qiao SB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jul; 46(7):529-535. PubMed ID: 30032543
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.